Deals
Kimberly-Clark Mulls Options for International Tissue Arm
- Advisers helping review tissue business outside North America
- A deal could value operations at around $4 billion: sources
A deal could value the business at around $4 billion, according to some of the people.
Photographer: Daniel Acker/BloombergThis article is for subscribers only.
Kimberly-Clark Corp. is exploring options for its international tissue business as part of its strategy to focus on more profitable areas, people with knowledge of the matter said.
The company is working with advisers to review its tissue operations outside North America, which could lead to a sale of part or all of the business, the people said. A deal could value the business at around $4 billion, according to some of the people, who asked not to be identified because the information is private.